EP3688162
SAMSETNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.9.2018EP published:
6.3.2024EP application number:
18800355.2
EP translation filed:
7.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
27.9.2038Expiry date:
27.9.2026Next due date:
30.9.2026
Title in English:
FORMULATIONSLanguage of the patent:
English
Timeline
Today
28.9.2018EP application
6.3.2024EP Publication
7.5.2024Translation submitted
15.6.2024Registration published
27.9.2026Expires
Owner
Name:
Intellia Therapeutics, Inc.Address:
40 Erie Street, Cambridge, MA 02139, US
Inventor
Name:
WOOD, Kristy, M.Address:
Wellesley, MA 02481, US
Name:
GARDNER, Noah, PaulAddress:
Sutton, MA 01590, US
Name:
SHAH, Ruchi, RudraprasadAddress:
Framingham, MA 01701, US
Name:
SCULLY, Stephen, S.Address:
Belmont, MA 02478, US
Name:
MAJZOUB, RamseyAddress:
Boston, MA 02114, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201762566240 PDate:
29.9.2017Country:
US
Classification
Categories:
C12N 15/113, C12N 15/88, C12N 9/22, A61K 9/127, A61K 31/7088
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 17.9.2024
Expires: 27.9.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.9.2025
Expires: 27.9.2026
Payer: Árnason Faktor ehf.